BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36401283)

  • 1. Integrating Single-cell RNA-seq to construct a Neutrophil prognostic model for predicting immune responses in non-small cell lung cancer.
    Pang J; Yu Q; Chen Y; Yuan H; Sheng M; Tang W
    J Transl Med; 2022 Nov; 20(1):531. PubMed ID: 36401283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation.
    Xiao B; Li G; Gulizeba H; Liu H; Sima X; Zhou T; Huang Y
    J Transl Med; 2024 May; 22(1):442. PubMed ID: 38730286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer.
    Zhou X; You L; Xin Z; Su H; Zhou J; Ma Y
    J Transl Med; 2023 Nov; 21(1):800. PubMed ID: 37950236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.
    Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X
    Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy.
    Li C; Pan J; Luo J; Chen X
    BMC Pulm Med; 2021 Nov; 21(1):389. PubMed ID: 34844602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating single-cell and bulk RNA sequencing to predict prognosis and immunotherapy response in prostate cancer.
    Wen XY; Wang RY; Yu B; Yang Y; Yang J; Zhang HC
    Sci Rep; 2023 Sep; 13(1):15597. PubMed ID: 37730847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq data reveals dynamic changes in tumor-associated neutrophils in the tumor microenvironment of hepatocellular carcinoma and leads to the establishment of a neutrophil-related prognostic model.
    Yang D; Zhou Y; Zhang Y; Su Y; Shen J; Yu B; Zhao K; Ding Y
    Cancer Immunol Immunother; 2023 Dec; 72(12):4323-4335. PubMed ID: 38006433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating scRNA-seq and bulk RNA-seq to characterize infiltrating cells in the colorectal cancer tumor microenvironment and construct molecular risk models.
    Wang Q; Zhang YF; Li CL; Wang Y; Wu L; Wang XR; Huang T; Liu GL; Chen X; Yu Q; He PF
    Aging (Albany NY); 2023 Dec; 15(23):13799-13821. PubMed ID: 38054820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation-related genes in tumor-associated macrophages as potential prognostic biomarkers in non-small cell lung cancer.
    Li Z; Zhou B; Zhu X; Yang F; Jin K; Dai J; Zhu Y; Song X; Jiang G
    Front Immunol; 2023; 14():1123840. PubMed ID: 36969247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq.
    Li Q; Wang R; Yang Z; Li W; Yang J; Wang Z; Bai H; Cui Y; Tian Y; Wu Z; Guo Y; Xu J; Wen L; He J; Tang F; Wang J
    Genome Med; 2022 Aug; 14(1):87. PubMed ID: 35962452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth single-cell and bulk-RNA sequencing developed a NETosis-related gene signature affects non-small-cell lung cancer prognosis and tumor microenvironment: results from over 3,000 patients.
    Zhang L; Zhang X; Guan M; Yu F; Lai F
    Front Oncol; 2023; 13():1282335. PubMed ID: 37927467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data.
    Zhao S; Zhang P; Niu S; Xie J; Liu Y; Liu Y; Zhao N; Cheng C; Lu P
    Funct Integr Genomics; 2024 Apr; 24(2):72. PubMed ID: 38594466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer.
    Guo S; Liu X; Zhang J; Huang Z; Ye P; Shi J; Stalin A; Wu C; Lu S; Zhang F; Gao Y; Jin Z; Tao X; Huang J; Zhai Y; Shi R; Guo F; Zhou W; Wu J
    Comput Biol Med; 2023 Jul; 161():107066. PubMed ID: 37263064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma.
    Jiang A; Wang J; Liu N; Zheng X; Li Y; Ma Y; Zheng H; Chen X; Fan C; Zhang R; Fu X; Yao Y
    Front Genet; 2022; 13():833797. PubMed ID: 35154287
    [No Abstract]   [Full Text] [Related]  

  • 18. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer.
    Liu X; Ma C; Liu H; Sun Z; Luo J
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data.
    Liu Y; Bie F; Bai G; Huai Q; Li Y; Chen X; Zhou B; Gao S
    Clin Transl Oncol; 2024 Apr; ():. PubMed ID: 38563846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hub genes of endothelial cells in glioblastoma-A prognostic model for GBM patients integrating single-cell RNA sequencing and bulk RNA sequencing.
    Zhao S; Ji W; Shen Y; Fan Y; Huang H; Huang J; Lai G; Yuan K; Cheng C
    BMC Cancer; 2022 Dec; 22(1):1274. PubMed ID: 36474171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.